Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 3
1995 1
1996 1
1999 1
2000 2
2001 4
2003 5
2004 5
2005 5
2006 3
2007 4
2008 3
2009 2
2011 3
2012 2
2013 3
2014 2
2015 3
2016 2
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Adjustment for continuous confounders: an example of how to prevent residual confounding.
Groenwold RH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KG; PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]). Groenwold RH, et al. CMAJ. 2013 Mar 19;185(5):401-6. doi: 10.1503/cmaj.120592. Epub 2013 Feb 11. CMAJ. 2013. PMID: 23401401 Free PMC article. Review. No abstract available.
Cardiovascular surveys: manual of operations.
Primatesta P, Allender S, Ciccarelli P, Doring A, Graff-Iversen S, Holub J, Panico S, Trichopoulou A, Verschuren WM; EUROCISS Research Group. Primatesta P, et al. Eur J Cardiovasc Prev Rehabil. 2007 Dec;14 Suppl 3:S43-61. doi: 10.1097/01.hjr.0000277988.18096.3b. Eur J Cardiovasc Prev Rehabil. 2007. PMID: 18091135 Review.
Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).
Sabaté M, Ferrer P, Ballarín E, Rottenkolber M, Amelio J, Schmiedl S, Reynolds R, Klungel O, Ibáñez L; PROTECT Work Package 2. Sabaté M, et al. Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):201-11. doi: 10.1111/bcpt.12358. Epub 2014 Dec 29. Basic Clin Pharmacol Toxicol. 2015. PMID: 25420967 Free article. Review.
The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.
Lebwohl M, Deodhar A, Griffiths CEM, Menter MA, Poddubnyy D, Bao W, Jehl V, Marfo K, Primatesta P, Shete A, Trivedi V, Mease PJ. Lebwohl M, et al. Among authors: primatesta p. Br J Dermatol. 2021 Nov;185(5):935-944. doi: 10.1111/bjd.20136. Epub 2021 Jun 8. Br J Dermatol. 2021. PMID: 33829482 Clinical Trial.
Guidelines and risk factor management.
Primatesta P. Primatesta P. Heart. 2005 Apr;91(4):417-8. doi: 10.1136/hrt.2004.048058. Heart. 2005. PMID: 15772181 Free PMC article.
Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.
Rottenkolber M, Voogd E, van Dijk L, Primatesta P, Becker C, de Groot MC, Plana E, Alvarez Y, Durand J, Slattery J, Afonso A, Requena G, Huerta C, Alvarez A, de Abajo F, Tauscher M, Hasford J, Fischer R, Reynolds R, Schmiedl S. Rottenkolber M, et al. Among authors: primatesta p. Respir Med. 2015 Jul;109(7):828-37. doi: 10.1016/j.rmed.2015.01.010. Epub 2015 Jan 31. Respir Med. 2015. PMID: 25976384 Free article.
A compilation of research working groups on drug utilisation across Europe.
Sabaté M, Pacheco JF, Ballarín E, Ferrer P, Petri H, Hasford J, Schoonen MW, Rottenkolber M, Fortuny J, Laporte JR, Ibáñez L; PROTECT Work Package 2. Sabaté M, et al. BMC Res Notes. 2014 Mar 13;7:143. doi: 10.1186/1756-0500-7-143. BMC Res Notes. 2014. PMID: 24625054 Free PMC article.
Alcohol and pregnancy: an international comparison.
Primatesta P, Del Corno G, Bonazzi MC, Waters WE. Primatesta P, et al. J Public Health Med. 1993 Mar;15(1):69-76. doi: 10.1093/oxfordjournals.pubmed.a042822. J Public Health Med. 1993. PMID: 8471303
51 results